Skip to content
Peptigraph home

Mazdutide for Heart Health: What the Evidence Shows

What human and animal studies show about Mazdutide for heart health, how strong that evidence is, and what is still unproven.

Medical review pendingGLP-1 / glucagon dual agonistUpdated
Strongest evidence
None graded
no study with an outcome for heart health (PubMed search, 2 Oct 2026)
Human studies
None found
with an outcome for heart health, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for heart health, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
1
with an outcome for heart health

Evidence for heart health

Each row is an outcome related to heart health from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Mazdutide for heart health: outcomes in published studies
OutcomeResultStudy typeSource
Blood pressure and cholesterolVersus placebo, systolic BP differed by -7.57 mmHg, diastolic BP by -2.98 mmHg, total cholesterol by -16.82%, triglycerides by -43.29% and LDL by -17.07%.Meta-analysisn = 680Frontiers in endocrinology 2024, PMID 38440786

Mazdutide and heart health are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our .

How strong is it?

Strongest evidence:No graded study for heart health (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Heart disease in plain terms

MedlinePlus says heart disease is a type of cardiovascular disease, meaning heart and blood vessel disease.[2]

Heart-related measures

In the meta-analysis, systolic blood pressure differed by -7.57 mmHg and diastolic by -2.98 mmHg versus placebo.[1]

The phase 2 registry record lists change from baseline in systolic blood pressure as a measure.[3]

The GLORY-1 record also registered change from baseline in systolic blood pressure.[4]

What no study shows

No cached study reports heart attacks, strokes or cardiovascular deaths with mazdutide; the cited results are blood pressure and cholesterol measures.

Calculated from studies cited 4; cardiovascular event outcomes 0. Formula: cardiovascular event outcomes among cited studies = 0

Other peptides people research for heart health

All peptides for heart health, compared

Common questions

Does Mazdutide help with heart health?

None of the studies we summarised for Mazdutide (PubMed search, 2 Oct 2026) measured an outcome for heart health. Treat claims that it helps with heart health as unproven.

Is Mazdutide approved for heart health?

No. Mazdutide is not FDA approved for any use, including heart health.

What is the best peptide for heart health?

There is no single answer. Our heart health overview compares each candidate by evidence grade and legal status rather than by popularity.

Does mazdutide lower blood pressure?

A meta-analysis reported lower blood pressure than placebo; blood pressure was a registered measure in two trials.[1]

More on Mazdutide

Sources

  1. 1Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials.Frontiers in endocrinology · 2024PMID 38440786Accessed 2 Oct 2026
  2. 2Official web pageOfficial web page · web page
  3. 3A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of IBI362 in Chinese Overweight and Obese SubjectsClinicalTrials.gov (U.S. National Library of Medicine) · 2021clinicaltrials.govAccessed 2 Oct 2026
  4. 4A Randomized, Double-blind, Placebo-controlled Phase III Study Evaluating the Efficacy and Safety of IBI362 in Chinese Participants With Obesity or Overweight (GLORY-1)ClinicalTrials.gov (U.S. National Library of Medicine) · 2022clinicaltrials.govAccessed 2 Oct 2026

Found an error? Report a correction.